Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro and Animal Models for Emerging Diseases and Biodefense
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dopaminergic Mechanisms Underlying Human Social Behavior: A Multimodal Approach
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
Molecular Pathway to Prostate Cancer
B-Rar - A Model Gene to Study Retinoid Teratogenicity
Pharmacogenetics of Mephenytoin Metabolism and Its Implications
Recently added grants:
SCH: INT: Collaborative Research: Multimodal Signal Analysis and Data Fusion for Post-traumatic Epilepsy
Mechanisms of Functional Axon Regeneration
Spreading Depolarizations and Brain Dysfunction Following Traumatic Brain Injury
Functional Validation of Intracranial Aneurysm Risk Genes
Exosome therapy for acute stroke with large artery occlusion
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI30065-9-0-1
Application #
7580027
Study Section
Project Start
2003-09-30
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense
/ University of Texas Medical Br Galveston
$2,025,158
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging infectious Diseases and Biodefense
/ University of Texas Medical Br Galveston
$1,366,579
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ University of Texas Medical Br Galveston
$1,309,766
NIH 2007
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense (IDIQ)
Stanberry, Lawernce /
$502,000
NIH 2007
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense
/
Comments
Be the first to comment on this grant